Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (Q97678476)
Jump to navigation
Jump to search
scientific article published on 20 July 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial |
scientific article published on 20 July 2020 |
Statements
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (English)
Merryn Voysey
Adrian V S Hill
Paul Heath
Andrew J Pollard
Katie J Ewer
Teresa Lambe
Sarah C Gilbert
Matthew Snape
Elizabeth A Clutterbuck
Brian Angus
Parvinder K Aley
Sandra Belij-Rammerstorfer
Sagida Bibi
Christina Dold
Adam Finn
Bassam Hallis
Rajeka Lazarus
Rebecca Makinson
Oxford COVID Vaccine Trial Group
Stephan Becker
Mustapha Bittaye
Maheshi Ramasamy
Hannah Robinson
Richard Tarrant